6533b81ffe1ef96bd12771cc
RESEARCH PRODUCT
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
Pier Paolo BassareoPaola NeroniJawahar L. MehtaVassilios FanosCesare De GregorioGianfranco ButeraGiuseppe Calcaterrasubject
2019-20 coronavirus outbreakPediatricsmedicine.medical_specialtyOpinionMyocarditisCoronavirus disease 2019 (COVID-19)Kawasaki-like syndromeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Myocarditis; Pericarditis; Multi-system inflammatory disease; Kawasaki-like syndrome; SARS-CoV-2multi-system inflammatory diseaseDiseasepericarditisPediatricsRJ1-570PericarditisVaccine administrationvaccinemedicineCritically illbusiness.industrySARS-CoV-2Rmedicine.diseaseMedicinemyocarditisbusinessdescription
The alarming onset of some cases of myocarditis and pericarditis following the administration of Pfizer–BioNTech and Moderna COVID-19 mRNA-based vaccines in adolescent males has recently been highlighted. All occurred after the second dose of the vaccine. Fortunately, none of patients were critically ill and each was discharged home. Owing to the possible link between these cases and vaccine administration, the US and European health regulators decided to continue to investigate the potential causal relationship between COVID-19 mRNA vaccines and myocarditis. In any case, none of the patients fulfilled the criteria for multi-system inflammatory syndrome or Kawasaki-like disease and there was no evidence of acute SARS-CoV-2 infection.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-09-01 | Pediatric Reports |